TRIGLYCERIDE-GLUCOSE INDEX: A POTENTIAL SURROGATE FOR INSULIN RESISTANCE IN PREDICTING THE RISK OF DIABETIC NEPHROPATHY

Main Article Content

Ashok Kumar Maheshwari
Iqra Badar
Kehf
Saleem Shahzad
Reema Akbar
Suresh Kumar

Keywords

.......

Abstract

This study was performed to explore how the triglyceride-glucose (TyG) index is related to insulin resistance, as measured by HOMA-IR, in patients newly diagnosed with type 2 diabetes mellitus (T2DM). It also examined how the TyG index is linked to UACR, a marker often used to detect early signs of diabetic nephropathy.


Study Design: Cross-sectional observational study.


Study Duration: This study was conducted at Peoples University of Medical and Health Sciences for Women Shaheed Benazirabad Nawabshah Hospital from March 2024 to March 2025


Methods:


An observational, cross-sectional study was carried out over a one-year. The study included adult patients with a recent diagnosis of T2DM. Data collected encompassed demographics (age, gender), clinical details (BMI, vitals, duration of diabetes), and key biochemical measurements: HOMA-IR, serum creatinine, TyG index, lipid profile, fasting plasma glucose, spot UACR, and fasting insulin. There were 4 quartiles in which the participants were categorized based on their TyG index scores; Quartile 1 (4.5 to 5), quartile 2 ( 5.1 to 5.5), quartile 3 (5.6 to 6), and quartile 4 (Above 6)

Abstract 186 | PDF Downloads 31

References

. Khan S, Qayyum NS, Muhammad. Triglyceride-glucose index: a surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy. Journal of the Pakistan Medical Association. 2024 Apr 22;74(5):862–7.
2. Er LK, Wu S, Chou HH, Hsu LA, Teng MS, Sun YC, et al. Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. Hribal ML, editor. PLOS ONE. 2016 Mar 1;11(3):e0149731.
3. Lee DY, Lee ES, Kim JH, Park SE, Park CY, Oh KW, et al. Predictive Value of Triglyceride Glucose Index for the Risk of Incident Diabetes: A 4-Year Retrospective Longitudinal Study. Guerrero-Romero F, editor. PLOS ONE. 2016 Sep 28;11(9):e0163465.
4. Locateli JC, Lopes WA, Simões CF, de Oliveira GH, Oltramari K, Bim RH, et al. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents. Journal of Pediatric Endocrinology and Metabolism. 2019 Oct 25;32(10):1163–70.
5. Palella E, Cimino R, Pullano SA, Fiorillo AS, Gulletta E, Brunetti A, et al. Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control. International Journal of Environmental Research and Public Health. 2020 Jan 1;17(1):300.
6. Malik R, Vanidassane I, Jain N. Study of Pulmonary function tests in Type 2 Diabetes Mellitus and their correlation with glycemic control and systemic inflammation. Advances in Respiratory Medicine. 2015 Mar 18;
7. Cho YR, Ann SH, Won KB, Park GM, Kim YG, Yang DH, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease according to the presence of diabetes. Scientific Reports [Internet]. 2019 Sep 2 [cited 2019 Nov 1];9(1). Available from: https://www.nature.com/articles/s41598-019-42700-1
8. Chan DC, Watts GF, Barrett PH, Mamo JC, Redgrave TG. Markers of Triglyceride-rich Lipoprotein Remnant Metabolism in Visceral Obesity. Clinical Chemistry. 2002 Feb 1;48(2):278–83.
9. Chiu H, Tsai HJ, Huang JC, Wu PY, Hsu WH, Lee MY, et al. Associations between Triglyceride-Glucose Index and Micro- and Macro-Angiopathies in Type 2 Diabetes Mellitus. Nutrients. 2020 Jan 26;12(2):328.
10. Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular Complications of Type 2 Diabetes Mellitus. Current Vascular Pharmacology. 2020 Jan 27;18(2):117–24.
11. Maslova OV, Suntsov YI. Epidemiology of diabetes mellitus and microvascular complications. Diabetes mellitus. 2011 Sep 15;14(3):6.
12. Krishna DC. Evaluation of Microvascular and Macrovascular complications in patients with Type 2 Diabetes Mellitus. Journal of Medical Science And clinical Research. 2020 Feb 20;08(02).
13. Wang J, Wang Y, Li Y, Hu Y, Jin L, Wang W, et al. High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study. Frontiers in Endocrinology [Internet]. 2022 May 20 [cited 2023 Dec 6];13. Available from: https://pubmed.ncbi.nlm.nih.gov/35669685
14. Look AHEAD Research Group. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes: One-year results of the Look AHEAD trial. Diabetes Care. 2007 Mar 15;30(6):1374–83.
15. Sasson AN. Renal hyperfiltration related to diabetes mellitus and obesity in human disease. World Journal of Diabetes. 2012;3(1):1.
16. Malik AR, Sultan S, Turner ST, Kullo IJ. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults. Journal of Human Hypertension. 2007 Jan 18;21(3):231–8.
17. Wang L, Cong H, Zhang J, Hu Y, Wei A, Zhang Y, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovascular Diabetology. 2020 Jun 13;19(1).
18. Irace C, Carallo C, Scavelli FB, De Franceschi MS, Esposito T, Tripolino C, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. International Journal of Clinical Practice. 2013 Jun 13;67(7):665–72.
19. Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS. The Lancet. 1982 Jun;319(8287):1430–2.

Most read articles by the same author(s)